Trombocytopenia in pregnant women [Text] / A. Zamojska [et al.] // Міжнародний журнал педіатрії, акушерства та гінекології. - 2018. - Т. 12, № 4. - P35-38. - Библиогр. в конце ст. MeSH-главная: ТРОМБОЦИТОПЕНИЯ -- THROMBOCYTOPENIA БЕРЕМЕННОСТЬ -- PREGNANCY ДИАГНОСТИКА -- DIAGNOSIS ТЕРАПЕВТИЧЕСКИЕ МЕТОДЫ И СРЕДСТВА -- THERAPEUTICS Аннотация: Thrombocytopenia is the second most commonly occurring haematological disorder in pregnant women after anaemia. It is usually characterized by a drop in platelet count below 150 G/L. Its course is mild and asymptomatic, although it may predispose to the occurrence of symptoms leading to life-threatening complications of pregnancy or exacerbation of the comorbid disease in pregnancy. In about 75% of cases associated with thrombocytopenia in pregnant women there is so-called gestational incidental thrombocytopenia (GIT), the pathomechanism of which is usually complex and associated with the course of pregnancy. The subsequent 20% of cases are associated with pre-eclampsia and HELLP syndrome. Primary immune thrombocytopenia accounts for 3-4%. Other types of thrombocytopenia in pregnant women constitute 1-2% (congenital, infection-related, drug-related, related with neoplastic diseases of the blood). The paper presents the influence of thrombocytopenia on the course of pregnancy in the light of literature. It also explains diagnostics and etiology, and takes into account the principles of therapeutic treatment Доп.точки доступа: Zamojska, A. Wankowicz, A. Golubka, P. Leszczynska-Gorzelak, B. Свободных экз. нет